The Pennant Group stock price target raised to $39 from $34 at RBC Capital

Published 17/11/2025, 14:46
The Pennant Group stock price target raised to $39 from $34 at RBC Capital

Investing.com - RBC Capital has raised its price target on The Pennant Group (NASDAQ:PNTG) to $39.00 from $34.00 while maintaining an Outperform rating on the stock. Currently trading at $24.90, PNTG appears undervalued according to InvestingPro analysis, with the stock trading 25% below its Fair Value despite showing robust revenue growth of nearly 30% over the last twelve months.

The price target increase represents a target enterprise multiple of 11.4x RBC’s revised 2026 adjusted EBITDAR estimate for the company. For context, PNTG currently trades at an EV/EBITDA multiple of 23.5x with a trailing twelve-month EBITDA of $50.6 million.

RBC Capital analyst Ben Hendrix indicated that the AMED asset acquisition is "likely underappreciated by the market," suggesting this was a key factor in the firm’s decision to raise its outlook.

The updated price target follows RBC’s Quick Take note published on November 5, in which the firm provided initial commentary on The Pennant Group’s third-quarter 2025 results.

The analyst has now updated the financial model for The Pennant Group, incorporating additional analysis of the company’s recent performance and the impact of the AMED acquisition.

In other recent news, Pennant Group announced its Q3 2025 earnings, which showed a significant shortfall in earnings per share (EPS). The company reported an EPS of $0.17, which was below the expected $0.30, marking a negative surprise of 43.33%. Despite this miss, Pennant Group’s revenue surpassed expectations, coming in at $229 million compared to the forecasted $222.72 million. This revenue beat did not prevent a decline in the company’s stock price, although stock price movements are not the focus here. These recent developments highlight the mixed financial performance of Pennant Group, with strong revenue growth but disappointing earnings per share.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.